NO975619D0 - Ekspresjon av lipoproteiner - Google Patents

Ekspresjon av lipoproteiner

Info

Publication number: NO975619D0
Authority: NO; Norway
Prior art keywords: protein; lipidated; disclosed; leader sequence; heterologous
Prior art date: 1995-06-07

Application number

NO975619A

Other languages

English (en)

Other versions

NO975619L (no

NO324089B1 (no

Inventor

Robert C Huebner

Lorne Franklin Erdile

Donald J Warakomski

Robert S Becker

Maryann B Gray

Derek L Pyle

Original Assignee

Connaught Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1997-12-04

Publication date

1997-12-04

1997-12-04 Application filed by Connaught Lab filed Critical Connaught Lab

1997-12-04 Publication of NO975619D0 publication Critical patent/NO975619D0/no

1998-01-30 Publication of NO975619L publication Critical patent/NO975619L/no

2007-08-13 Publication of NO324089B1 publication Critical patent/NO324089B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Immunology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
General Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO19975619A 1995-06-07 1997-12-04 Hybrid nukleinsyremolekyl for fremstilling av lipiderte rekombinante proteiner fra Borrelia-arter. NO324089B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US47578195A	1995-06-07	1995-06-07
US48637395A	1995-06-07	1995-06-07
PCT/IB1996/000633 WO1996040718A1 (en)	1995-06-07	1996-06-05	Expression of lipoproteins

Publications (3)

Publication Number	Publication Date
NO975619D0 true NO975619D0 (no)	1997-12-04
NO975619L NO975619L (no)	1998-01-30
NO324089B1 NO324089B1 (no)	2007-08-13

Family

ID=27044930

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO19975619A NO324089B1 (no)	1995-06-07	1997-12-04	Hybrid nukleinsyremolekyl for fremstilling av lipiderte rekombinante proteiner fra Borrelia-arter.
NO20064621A NO20064621L (no)	1995-06-07	2006-10-09	Ekspresjon av lipoproteiner.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20064621A NO20064621L (no)	1995-06-07	2006-10-09	Ekspresjon av lipoproteiner.

Country Status (13)

Country	Link
EP (2)	EP0832093B1 (no)
JP (1)	JP4091112B2 (no)
AT (1)	ATE339436T1 (no)
AU (1)	AU721954B2 (no)
CA (2)	CA2223300C (no)
DE (1)	DE69636544T2 (no)
DK (1)	DK0832093T3 (no)
ES (1)	ES2271954T3 (no)
FI (1)	FI974422L (no)
IL (1)	IL118578A (no)
NO (2)	NO324089B1 (no)
PT (1)	PT832093E (no)
WO (1)	WO1996040718A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7008625B2 (en)	1993-11-01	2006-03-07	Research Foundation Of The State University Of New York	Recombinant constructs of Borrelia burgdorferi
ZA964896B (en) *	1995-06-07	1997-01-08	Connaught Lab	Expression of lipoproteins
AU2003204215B2 (en) *	1998-02-03	2007-01-11	Aventis Pasteur	Recombinant Lipidated PsaA Protein, Methods of Preparation and Use
WO1999040200A1 (en) *	1998-02-03	1999-08-12	Center For Disease Control And Prevention	RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
EP1790660B1 (en) *	2000-02-28	2012-06-20	Novartis Vaccines and Diagnostics S.r.l.	Heterologous expression of neisserial proteins
EP1311540B1 (en)	2000-08-18	2007-12-19	Research Foundation Of State University Of New York	Altered ospa of borrelia burgdorferi
MY144532A (en)	2001-08-20	2011-09-30	Lundbeck & Co As H	Novel method for down-regulation of amyloid
MX339524B (es)	2001-10-11	2016-05-30	Wyeth Corp	Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
DK1812058T3 (da)	2004-10-25	2012-09-17	Statens Seruminstitut	Chlamydia Trachomatis antigener til vaccine og diagnostisk anvendelse
CA2836319A1 (en)	2005-06-23	2006-12-28	Statens Serum Institut	Tuberculosis vaccines comprising antigens expressed during the latent infection phase
CA2936822C (en)	2006-01-19	2021-09-14	Mary Kay, Inc.	Skin care compositions comprising kakadu plum extract
US20090324638A1 (en) *	2006-06-12	2009-12-31	Biopeptides Corp.	Live bacterial vaccine
AR064642A1 (es)	2006-12-22	2009-04-15	Wyeth Corp	Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
PL2199303T3 (pl)	2008-12-12	2013-11-29	Euroimmun Medizinische Labordiagnostika Ag	Polipeptydy i sposoby swoistego wykrywania przeciwciał u pacjentów z zakażeniem krętkami Borrelia
AU2010238943B9 (en)	2009-04-24	2015-10-15	Statens Serum Institut	A tuberculosis TB vaccine to prevent reactivation
KR101772139B1 (ko)	2009-08-28	2017-08-28	마리 케이 인코포레이티드	피부 케어 제형
MX350142B (es)	2010-08-23	2017-08-28	Wyeth Llc *	Formulaciones estables de antigenos rlp2086 de neisseria meningitidis.
SG187912A1 (en)	2010-09-10	2013-04-30	Wyeth Llc	Non-lipidated variants of neisseria meningitidis orf2086 antigens
SA115360586B1 (ar)	2012-03-09	2017-04-12	فايزر انك	تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
KR101763625B1 (ko)	2012-03-09	2017-08-01	화이자 인코포레이티드	수막염균 조성물 및 이의 사용 방법
WO2014136064A2 (en)	2013-03-08	2014-09-12	Pfizer Inc.	Immunogenic fusion polypeptides
CA2923129C (en)	2013-09-08	2020-06-09	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
CN107249626A (zh)	2015-02-19	2017-10-13	辉瑞大药厂	脑膜炎奈瑟球菌组合物及其方法
PE20191107A1 (es)	2017-01-31	2019-08-26	Pfizer	Composiciones de neisseria meningitidis y metodos respectivos
CA3155669A1 (en)	2019-09-27	2021-04-01	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4624926A (en) *	1981-01-02	1986-11-25	The Research Foundation Of State University Of New York	Novel cloning vehicles for polypeptide expression in microbial hosts
WO1993008306A1 (en) *	1991-10-22	1993-04-29	Symbicom Aktiebolag	Improvement in borrelia burgdorferi diagnosis and prophylaxis
CA2032914A1 (en) *	1989-12-26	1991-06-27	Peter C.K. Lau	Use of bacterial lipoprotein amino terminus in fusion plasmids for in vivo expression of lipid modified polypeptides
SG47447A1 (en) *	1990-06-15	1998-04-17	Univ Yale	Compositions and methods for the prevention and diagnosis of lyme disease
ZA921025B (en) *	1991-02-15	1992-11-25	Uab Research Foundation	Structural gene of pneumococcal protein
AU5958594A (en) *	1992-12-24	1994-07-19	Med Immune, Inc.	Method of protection against (streptococcus pneumoniae) with transformed mycobacteria

1996
- 1996-06-05 IL IL118578A patent/IL118578A/en not_active IP Right Cessation
- 1996-06-05 WO PCT/IB1996/000633 patent/WO1996040718A1/en not_active Ceased
- 1996-06-05 CA CA2223300A patent/CA2223300C/en not_active Expired - Fee Related
- 1996-06-05 DE DE69636544T patent/DE69636544T2/de not_active Expired - Lifetime
- 1996-06-05 CA CA2704354A patent/CA2704354A1/en not_active Abandoned
- 1996-06-05 ES ES96918793T patent/ES2271954T3/es not_active Expired - Lifetime
- 1996-06-05 DK DK96918793T patent/DK0832093T3/da active
- 1996-06-05 PT PT96918793T patent/PT832093E/pt unknown
- 1996-06-05 AT AT96918793T patent/ATE339436T1/de active
- 1996-06-05 FI FI974422A patent/FI974422L/fi not_active Application Discontinuation
- 1996-06-05 EP EP96918793A patent/EP0832093B1/en not_active Expired - Lifetime
- 1996-06-05 AU AU61343/96A patent/AU721954B2/en not_active Ceased
- 1996-06-05 JP JP50026897A patent/JP4091112B2/ja not_active Expired - Fee Related
- 1996-06-05 EP EP06016140A patent/EP1741718A3/en not_active Withdrawn
1997
- 1997-12-04 NO NO19975619A patent/NO324089B1/no not_active IP Right Cessation
2006
- 2006-10-09 NO NO20064621A patent/NO20064621L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP0832093A1 (en)	1998-04-01
DE69636544T2 (de)	2007-06-06
DK0832093T3 (da)	2007-01-08
EP1741718A3 (en)	2007-03-28
DE69636544D1 (de)	2006-10-26
FI974422A7 (fi)	1998-02-04
AU721954B2 (en)	2000-07-20
IL118578A (en)	2006-12-31
EP1741718A2 (en)	2007-01-10
ES2271954T3 (es)	2007-04-16
EP0832093A4 (en)	2001-01-03
FI974422A0 (fi)	1997-12-05
ATE339436T1 (de)	2006-10-15
NO20064621L (no)	1998-01-30
JPH11514841A (ja)	1999-12-21
AU6134396A (en)	1996-12-30
NO975619L (no)	1998-01-30
NO324089B1 (no)	2007-08-13
JP4091112B2 (ja)	2008-05-28
EP0832093B1 (en)	2006-09-13
PT832093E (pt)	2006-12-29
CA2223300C (en)	2010-07-27
CA2704354A1 (en)	1996-12-19
CA2223300A1 (en)	1996-12-19
WO1996040718A1 (en)	1996-12-19
FI974422L (fi)	1998-02-04
IL118578A0 (en)	1996-10-16

Publication	Publication Date	Title
NO975619D0 (no)	1997-12-04	Ekspresjon av lipoproteiner
DK0954588T3 (da)	2007-05-14	OB fusionsprotein-sammensætninger og fremgangsmåder
IT8520226A0 (it)	1985-04-04	Sistema di controllo per motore commutato elettronicamente, sistema di motore commutato elettronicamente, macchina lavabiancheria e metodi per controllare la medesima.
NL1002111A1 (nl)	1996-07-18	Stabilisatorcombinatie.
WO1997034316A3 (en)	1997-10-23	Interconnection routing system
ID29065A (id)	2001-07-26	Penghambat-penghambat farnesil protein transferase
DE69528180D1 (de)	2002-10-17	Modifiziertes molkeprotein
NL1006820A1 (nl)	1998-02-26	Stabilisatormengsels.
FI972384L (fi)	1997-06-05	Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-terminaalisia sulfonyyli- tai amidinosulfonyyliryhmiä
IT1307309B1 (it)	2001-10-30	Peptidi stabilizzanti, polipeptidi ed anticorpi che li comprendono.
FR2702361B1 (fr)	1997-10-24	Fixateur pour les ostéosynthèses lombo-sacrées.
NL193766B (nl)	2000-05-01	Geïsoleerde draad.
DE69933509D1 (de)	2006-11-23	Roboter Steuerungssystem
DE19681312T1 (de)	1998-04-16	Datenverbindungs-Steuerverfahren
HU9202074D0 (en)	1992-10-28	Collagen binding protein qnd method for producing it
TR27243A (tr)	1994-12-21	Antimikrobiyal proteinler.
FR2701833B1 (fr)	1995-04-14	Fixateur pour les ostéosynthèses lombo-sacrées.
ZA99677B (en)	1999-09-02	Placental protein 13.
FI965228L (fi)	1997-02-26	Menetelmä 1,4-butaanidiolin valmistamiseksi
NL1005505A1 (nl)	1997-09-17	Servobesturingsinrichting.
FR2739622B1 (fr)	1997-12-05	Nouvelles proteines membranaires d'helicobacter pylori
EP0918796A4 (en)	2002-11-06	MONOCLONAL ANTIBODY FOR AGGLUTINATION BY E. COLI, CONTAINING A PROTEIN FROM THE CS4 / CFA FAMILY
FR2700920B1 (fr)	1995-04-21	Passage sélectif pour bétail.
BR9708948A (pt)	1999-08-03	1,3 - Benzodioxois substituídos
FI94051B (fi)	1995-03-31	Pectinatus-bakteerin proteiinifragmentteja

Legal Events

Date	Code	Title	Description
2015-01-26	MM1K	Lapsed by not paying the annual fees